Drug · DIN 02493993
HALOPERIDOL INJECTION
No: cancelled
Cancelled by Health Canada because the company did not file its annual notification.
Status Cancelled (Unreturned Annual) since January 9, 2023.
- Drug Identification Number (DIN)
- 02493993
- Company (DIN owner)
- Neo Health Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intramuscular
- Therapeutic class (ATC)
- Haloperidol N05AD01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HALOPERIDOL | 5 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 12, 2019: NOC 22890Abbreviated New Drug Submission (ANDS)
Other DINs named HALOPERIDOL INJECTION
- DIN 02366010 · Marketed
- DIN 02540223 · Cancelled Pre Market